ORPHAN SYNERGY EUROPE-PHARMA (EPA:OSE) | Finanzwire

Basculer en Français

8609	Companies
141554	Keywords
77460	Articles
75647	Press releases

Headlines Articles Press releases ORPHAN SYNERGY EUROPE-PHARMA

Home
Companies
ORPHAN SYNERGY EUROPE-PHARMA

BRIEF

published on 06/20/2024 at 07:35, 9 months 20 days ago

OSE Immunotherapeutics presents promising data on the mRNA platform at the FOCIS congress

Autoimmune Diseases OSE Immunotherapeutics FOCIS 2024 IL-35 Therapeutic MRNA
BRIEF

published on 06/05/2024 at 07:35, 10 months 5 days ago

OSE Immunotherapeutics and Nantes University Hospital Present Positive Results in Renal Transplantation

Immunotherapy Clinical Test OSE Immunotherapeutics FR104/VEL-101 Kidney Transplantation
PRESS RELEASE

published on 06/05/2024 at 07:30, 10 months 5 days ago

OSE Immunotherapeutics and Nantes University Hospital Present Positive Phase 1/2 Study Evaluating FR104/VEL-101 Immunotherapy in Renal Transplant
OSE Immunotherapeutics and Nantes University Hospital present positive Phase 1/2 study evaluating FR104/VEL-101 immunotherapy in renal transplant at American Transplant Congress 2024

Immunotherapy Phase 1/2 Study OSE Immunotherapeutics Nantes University Hospital Renal Transplant
BRIEF

published on 05/22/2024 at 07:35, 10 months 19 days ago

OSE Immunotherapeutics and Boehringer Ingelheim Expand Collaboration for Novel Treatments

Collaboration Immunotherapy Cancer Cardio-renal-metabolic
PRESS RELEASE

published on 05/22/2024 at 07:30, 10 months 19 days ago

OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treatments for cancer and cardio-renal-metabolic diseases
OSE Immunotherapeutics and Boehringer Ingelheim expand partnership to develop first-in-class therapies for cancer and cardio-renal-metabolic diseases, aiming to address unmet patient needs

Partnership Cancer Boehringer Ingelheim OSE Immunotherapeutics First-in-class Treatments
PRESS RELEASE

published on 05/26/2023 at 08:15, 1 year 10 months ago

OSE Immunotherapeutics (OSE): Re-initiation – Milestones anticipated throughout FY23

Accesswire

Published on 04/11/2025 at 02:40, 2 hours 30 minutes ago

McFarlane Lake Announces Closing of Final Tranche of Upsized $1.3 Million Private Placement Offering
Published on 04/11/2025 at 02:00, 3 hours 10 minutes ago

Battery X Metals Announces Formation of Critical Battery Metals Exploration Subsidiary and Expansion of Quebec Exploration Portfolio with Acquisition of 39 Additional Mineral Claims
Published on 04/11/2025 at 00:00, 5 hours 10 minutes ago

Onco-Innovations’ Inka Health Publishes Roche-Sponsored Study Advancing Real-World Oncology Research
Published on 04/10/2025 at 23:05, 6 hours 5 minutes ago

Caldwell Reports Second Quarter Results
Published on 04/10/2025 at 23:00, 6 hours 10 minutes ago

Highlander Silver Receives Conditional Approval to List on the TSX, Files Base Shelf Prospectus and Establishes ATM Program as Longer Term Financial Alternatives

View all ACCESSWIRE

EQS Group

Published on 04/11/2025 at 05:00, 10 minutes ago

LISA with Leading Thai and International Artists Captivate the World at the Amazing Thailand Countdown 2025, Reinforcing ICONSIAM as the Ultimate Global Countdown Destination
Published on 04/10/2025 at 20:47, 8 hours 23 minutes ago

EQS-Adhoc: Hinkel & Cie. GmbH: first creditors´meeting of the bond DE000A2AAPX4
Published on 04/10/2025 at 20:44, 8 hours 26 minutes ago

EQS-Adhoc: artnet AG: artnet is in talks with two investors regarding a potential takeover offer
Published on 04/10/2025 at 19:00, 10 hours 10 minutes ago

Immunic, Inc. Announces Closing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments
Published on 04/10/2025 at 18:57, 10 hours 13 minutes ago

EQS-Adhoc: HAMBORNER REIT AG: Adjustment of dividend strategy

Les Echos

Published on 04/10/2025 at 17:45, 11 hours 25 minutes ago

EURAZEO INVESTS IN EKOSCAN INTEGRITY, A LEADING GLOBAL PROVIDER OF ADVANCED NON-DESTRUCTIVE TESTING SOLUTIONS FOR CRITICAL INDUSTRIAL APPLICATIONS AND INFRASTRUCTURE
Published on 04/10/2025 at 17:27, 11 hours 43 minutes ago

2024 URD - Universal Registration Document
Published on 04/09/2025 at 18:59, 1 day 10 hours ago

Description of the 2025-2026 Share Buyback Program
Published on 04/09/2025 at 18:57, 1 day 10 hours ago

Minutes of the Combined General Meeting held on April 9, 2025
Published on 04/09/2025 at 17:45, 1 day 11 hours ago

COGELEC : 2024 full-year results and Q1 2025 revenue.

View all LES ECHOS COMFI WIRE